Skip to main content
. 2021 Jun 14;11:698465. doi: 10.3389/fonc.2021.698465

Figure 6.

Figure 6

The prognostic value of IRF4 in LUAD patients with immunotherapy. (A, B). Correlation of IRF4 expression with PDCD1 (A) and CD274 (B) expression in TCGA-LUAD cohort (n = 515). (C) Survival curves of progression free survival based on IRF4 expression in GSE93157-LUAD-cohort (n = 22). LUAD, Lung adenocarcinoma.